- Global Pharma News & Resources

Global Fill Finish Manufacturing Market (2022 to 2027) - Growth, Trends, COVID-19 Impact and Forecasts -

DUBLIN--(BUSINESS WIRE)--The "Fill Finish Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to's offering.

The Fill Finish Manufacturing Market is expected to register a CAGR of 8.7% during the forecast period.

Companies Mentioned

  • Becton, Dickinson and Company
  • Optima
  • West Pharmaceutical Services, Inc
  • IMA S.P.A
  • Groninger & Co GmbH
  • Schott AG
  • Nipro Medical Corporation
  • Gerresheimer AG
  • Piramal Pharma Solutions
  • Syntegon Technology GmbH (Robert Bosch GmbH)

Key Market Trends

Consumables segment is Expected to Hold a Major Market Share in the Fill Finish Manufacturing Market

Consumables segment is categorized into cartridges, prefillable syringes, vials, and other consumables such as ampoules, bottles, bags, and single-use systems. Prefilled syringes are highly preferred due to ease of administration, safety, biologically sterile, time and accuracy benefits. As per Congressional Research Service, the use of biologics and spending on these products has been increasing. For example, the United States has spent 120.1 billion dollars on biologics in the year 2017, about a 12.5% increase compared to the year 2016.

Consumables segment hold a significant market share in the fill finish manufacturing market and is anticipated to a show similar trend over the forecast period due to high replacement rate compared to instruments, shelf life of consumables is less and required in large quantity. Rising adoption of prefilled syringes, wide applications of vials in lyophilization and increasing fill finish outsourcing are the key driving factors in the consumables segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the fill finish manufacturing market due to the presence of a number of pharmaceutical and biopharmaceutical companies with large production capacities in this region. North America holds a significant market share in the fill finish manufacturing market and is anticipated to show a similar trend over the forecast period. Furthermore, the growing emphasis on superior biopharmaceutical products, the emergence of the biosimilar market and patent expiry of biologic products is also fueling the growth of the overall regional market to a large extent.

Key Topics Covered:





4.1 Market Overview

4.2 Market Drivers

4.2.1 Technological Advancement in Fill Finish Products

4.2.2 Rise in Fill Finish Outsourcing

4.3 Market Restraints

4.3.1 Stringent Regulatory Issues

4.3.2 High Production Costs

4.4 Porter's Five Force Analysis


5.1 By Product Type

5.1.1 Consumables Prefillable Syringes Cartridges Vials Other Consumables

5.2 By End User

5.2.1 Contract Manufacturing Organizations

5.2.2 Pharmaceutical and Biotechnology Industries

5.2.3 Others

5.3 Geography

5.3.1 North America United States Canada Mexico

5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe

5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa

5.3.5 South America Brazil Argentina Rest of South America


6.1 Company Profiles


For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 01-Mar-2022